Ceribell (CBLL) Change in Account Payables (2023 - 2026)
Ceribell's (CBLL) quarterly Change in Account Payables came in at -$857000.0 in Q1 2026, down 348.41% YoY from $345000.0 in Q1 2025, and down 245.5% on a QoQ basis from $589000.0 in Q4 2025.
Ceribell (CBLL) Change in Account Payables (2023 - 2026) Analysis & Trends
Ceribell (CBLL) has 4 years of Change in Account Payables data on file, last reported at -$857000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 348.41% year-over-year to -$857000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $543000.0 (up 86.6% YoY) and the FY2025 annual result came in at $1.7 million, up 598.0% from the prior year.
- Change in Account Payables slipped to -$857000.0 in Q1 2026, from $589000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.0 million in Q2 2025 to a low of -$903000.0 in Q4 2024.
- A 4-year average of $59900.0 and a median of $151000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2025 — Change in Account Payables soared 50900.0% — and 2026, when it plunged 348.41%.
- Tracing CBLL's Change in Account Payables over 4 years: stood at -$539000.0 in 2023, then sank by 67.53% to -$903000.0 in 2024, then jumped by 165.23% to $589000.0 in 2025, then plunged by 245.5% to -$857000.0 in 2026.
- The last three Change in Account Payables figures came in at -$857000.0 (Q1 2026), $589000.0 (Q4 2025), and -$205000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Ceribell | 921.14 Mn | 791.87 Mn | 25.94 Mn | 1.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.26 Mn |
| Jun 30, 2026 | 1.26 Mn |
| Mar 31, 2026 | -857,000.00 |
| Mar 31, 2026 | -857,000.00 |
| Dec 31, 2025 | 589,000.00 |
| Dec 31, 2025 | 589,000.00 |
| Sep 30, 2025 | -205,000.00 |
| Sep 30, 2025 | -205,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 345,000.00 |
| Mar 31, 2025 | 345,000.00 |
| Dec 31, 2024 | -903,000.00 |
| Dec 31, 2024 | -903,000.00 |
| Sep 30, 2024 | 851,000.00 |
| Sep 30, 2024 | 851,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | 304,000.00 |
| Mar 31, 2024 | 304,000.00 |